InTouch
July / August 2026

ISPE AI Summit and AI Guide: Driving AI Adoption in Pharma

Gabriela Kantor
GAMP-AI_cover-750px.jpg

ISPE’s 2026 AI in Life Sciences Summit—Powered by GAMP® brought together a diverse group of regulators and pharmaceutical and technology professionals to address the growing opportunities and challenges for applying artificial intelligence (AI) in the pharmaceutical industry and to explore the rapidly evolving role of AI in regulated environments.

As part of the broader AI initiative, the  ISPE GAMP® Guide: Artificial Intelligence provides a comprehensive, state-of-the-art framework for developing and managing AI-enabled computerized systems in regulated life sciences. Building on established GAMP® 5 principles, the Guide bridges traditional validation approaches and AI’s unique characteristics, offering a structured, yet flexible model for achieving compliant, high-quality systems. It complements existing guidance on data integrity, records management, and risk-based validation and it introduces new concepts tailored to AI technologies.

Growing industry challenges prompted the need for this Guide. Since 2019, the GAMP® Community of Practice—particularly the Software Automation and AI Special Interest Group—observed a surge in questions around AI validation, especially following advances in generative AI. Organizations struggled with several recurring issues: limited AI literacy, unclear regulatory expectations, fragmented data, evolving cybersecurity threats, and lack of alignment with suppliers. These gaps led to uncertainty in risk management and difficulties in defining appropriate control strategies.

As a result, many AI initiatives failed or stalled, often at the pilot stage. With an estimated failure rate as high as 80% (significantly higher than traditional information technology projects), the stakes became clear. Failures not only waste resources, but they also delay potential benefits like improved patient outcomes, enhanced manufacturing efficiency, and better process control.

The  ISPE GAMP® Guide: Artificial Intelligence addresses these challenges by providing a holistic best practice framework. It emphasizes quality risk management as a central principle, helping organizations identify, assess, and control AI-specific risks. The Guide promotes scalable life-cycle activities, encouraging organizations to tailor processes based on system complexity and risk profile. It also establishes a common language across stakeholders—regulated companies, suppliers, service providers, and regulators—enabling clearer collaboration and accountability.

A key strength of the Guide is its focus on data and model governance. It introduces the concept of fit-for-purpose data and expands governance practices to ensure robust, traceable, and reliable model development. The Guide also addresses model life-cycle activities, including ideation, proof-of-concept, development, testing, deployment, and monitoring. It highlights the importance of continuous performance evaluation using live data, enabling controlled evolution and continual improvement of AI systems.

The Guide outlines critical supporting disciplines such as change management, corrective and preventive action processes, cybersecurity, and knowledge management. It emphasizes the importance of building AI literacy and integrating specialized roles such as data scientists into existing organizational structures. Concepts such as explainable AI and trustworthy AI are also central, as they help promote transparency, bias mitigation, and human oversight to ensure ethical and responsible use.

Ultimately, the ISPE GAMP® Guide: Artificial Intelligence enables organizations to innovate responsibly while maintaining compliance in GxP-regulated environments. As AI continues to reshape life sciences, the Guide serves as both a foundational framework and a starting point for continued collaboration across the industry.

View Guide


About Pharmaceutical Engineering

ISPE members receive an annual subscription to ISPE’s award-winning Pharmaceutical Engineering magazine as part of their membership benefits. Published six times yearly, each issue features contributions from expert authors and technical articles highlighting the latest industry trends and innovations.

Learn more

Join ISPE Today

Becoming a member of ISPE offers numerous benefits, including access to a vast network of professionals, exclusive training events, and valuable resources. As a member, you'll join more than 22,000 of your professional peers from over 120 countries in advancing solutions that lead to improved patient health. Membership provides access to 20+ complimentary ISPE Good Practice Guides, a robust library of on-demand training and e-learning resources, and much more. Learn more and consider joining today.

Become an ISPE member 

ISPE members: Get more involved by volunteering.